You are here

  • Home
  • Archive
  • Volume 12, Issue 2
  • Efficacy and safety of autologous tumor-infiltrating lymphocytes in recurrent or refractory ovarian cancer, colorectal cancer, and pancreatic ductal adenocarcinoma

Article metrics

Article menu
Immune cell therapies and immune cell engineering
Original research
Efficacy and safety of autologous tumor-infiltrating lymphocytes in recurrent or refractory ovarian cancer, colorectal cancer, and pancreatic ductal adenocarcinoma

 

Online download statistics by month:

Online download statistics by month: February 2024 to February 2026

AbstractFullPdf
Feb 202412931310456
Mar 2024347348223
Apr 2024422425181
May 2024216225129
Jun 2024233235110
Jul 2024265274110
Aug 202416816999
Sep 202418618999
Oct 202419920189
Nov 2024232234114
Dec 2024263267130
Jan 2025220221121
Feb 2025341342147
Mar 2025260263202
Apr 2025279279148
May 2025251256167
Jun 202510310356
Jul 2025110
Oct 202510104
Nov 2025221
Feb 2026110
Total529253552586